Advanced Oncology Certified Nurse Practitioner (AOCNP) Certification Practice Test

Triple-negative breast cancer is often bilateral and has a strong association with BRCA mutations, particularly BRCA1. Individuals with BRCA mutations have a higher risk of developing breast cancer at a younger age, and the subtype commonly seen in these patients is triple-negative. This subtype is characterized by the absence of estrogen receptors, progesterone receptors, and HER2 overexpression, making it distinct from other types of breast cancer. BRCA1 mutations, specifically, are linked to a more aggressive breast cancer phenotype that tends to be triple-negative and frequently presents in both breasts (bilateral). Therefore, recognizing the association between BRCA mutations and triple-negative breast cancer is crucial for screening, prevention strategies, and treatment planning for those at high risk.